The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas

E. Buiatti, A. Barchielli, S. Bartolacci, M. Federico, V. De Lisi, L. Bucchi, S. Ferretti, E. Paci, N. Segnan, R. Tumino, D. Balzi, R. Negri, E. Artioli, F. Falcini, E. Crocetti, D. Giorgi, A. C. Finarelli, A. Ponti, G. Ronco, M. VettorazziS. Patriarca, S. Rosso, R. Zanetti

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The aim of this study was to examine the effects of mammographic screening programmes on stage-specific incidence of breast cancer. The study compared prescreening and screening periods in seven areas in Italy, primarily evaluating the first screening round. All 17 617 breast cancers (16 554 invasive, 1063 in situ) registered in women aged 40-79 years between 1988 and 1999 were analysed through age-standardised rates and Poisson regression models. For all areas, independent of the baseline rates, the introduction of screening increased incidence for invasive cancers overall and, more markedly, for early cancers (screening/prescreening ratio: range 1.07-1.47 and 1.23-1.82, respectively), modifying the pattern of age-specific rates. The multiple regression analysis showed that the percentage of cases diagnosed at screening explained most of the increase; a residual effect of diagnosis period (screening versus prescreening) suggested a role for 'spontaneous' early detection in ages outside of the screening programme. Advanced cases did not show consistent variations across the registries for those aged 40-79 years (range: 0.91-1.21), whereas a more coherent picture was observed for those aged 50-69 years. In one area, a moderate reduction in the number of 'advanced' cases in the second screening period was observed. For all stages, the age-specific incidence rates of cases diagnosed outside of the screening programme for the age groups 50-69 years were lower than the corresponding rates in the prescreening period, suggesting a shift from the usual clinical services to the screening programme. Our results confirmed the increase in early-stage cancers occurring at the start of screening, and substantially explained the rise in breast cancer incidence. In addition, our study confirms the importance of cancer registries in monitoring the effect of breast cancer screening and the validity, for this purpose, of the linkage between cancer registries and screening programme databases.

Original languageEnglish
Pages (from-to)1776-1782
Number of pages7
JournalEuropean Journal of Cancer
Volume39
Issue number12
DOIs
Publication statusPublished - Aug 2003

Fingerprint

Early Detection of Cancer
Breast Neoplasms
Registries
Incidence
Neoplasms
Italy
Age Groups
Regression Analysis
Databases

Keywords

  • Breast cancer
  • Cancer registry
  • Incidence
  • Mammographic screening
  • Stage

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas. / Buiatti, E.; Barchielli, A.; Bartolacci, S.; Federico, M.; De Lisi, V.; Bucchi, L.; Ferretti, S.; Paci, E.; Segnan, N.; Tumino, R.; Balzi, D.; Negri, R.; Artioli, E.; Falcini, F.; Crocetti, E.; Giorgi, D.; Finarelli, A. C.; Ponti, A.; Ronco, G.; Vettorazzi, M.; Patriarca, S.; Rosso, S.; Zanetti, R.

In: European Journal of Cancer, Vol. 39, No. 12, 08.2003, p. 1776-1782.

Research output: Contribution to journalArticle

Buiatti, E, Barchielli, A, Bartolacci, S, Federico, M, De Lisi, V, Bucchi, L, Ferretti, S, Paci, E, Segnan, N, Tumino, R, Balzi, D, Negri, R, Artioli, E, Falcini, F, Crocetti, E, Giorgi, D, Finarelli, AC, Ponti, A, Ronco, G, Vettorazzi, M, Patriarca, S, Rosso, S & Zanetti, R 2003, 'The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas', European Journal of Cancer, vol. 39, no. 12, pp. 1776-1782. https://doi.org/10.1016/S0959-8049(03)00322-8
Buiatti, E. ; Barchielli, A. ; Bartolacci, S. ; Federico, M. ; De Lisi, V. ; Bucchi, L. ; Ferretti, S. ; Paci, E. ; Segnan, N. ; Tumino, R. ; Balzi, D. ; Negri, R. ; Artioli, E. ; Falcini, F. ; Crocetti, E. ; Giorgi, D. ; Finarelli, A. C. ; Ponti, A. ; Ronco, G. ; Vettorazzi, M. ; Patriarca, S. ; Rosso, S. ; Zanetti, R. / The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas. In: European Journal of Cancer. 2003 ; Vol. 39, No. 12. pp. 1776-1782.
@article{22f919175cea49588444fcdcc34d9aba,
title = "The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas",
abstract = "The aim of this study was to examine the effects of mammographic screening programmes on stage-specific incidence of breast cancer. The study compared prescreening and screening periods in seven areas in Italy, primarily evaluating the first screening round. All 17 617 breast cancers (16 554 invasive, 1063 in situ) registered in women aged 40-79 years between 1988 and 1999 were analysed through age-standardised rates and Poisson regression models. For all areas, independent of the baseline rates, the introduction of screening increased incidence for invasive cancers overall and, more markedly, for early cancers (screening/prescreening ratio: range 1.07-1.47 and 1.23-1.82, respectively), modifying the pattern of age-specific rates. The multiple regression analysis showed that the percentage of cases diagnosed at screening explained most of the increase; a residual effect of diagnosis period (screening versus prescreening) suggested a role for 'spontaneous' early detection in ages outside of the screening programme. Advanced cases did not show consistent variations across the registries for those aged 40-79 years (range: 0.91-1.21), whereas a more coherent picture was observed for those aged 50-69 years. In one area, a moderate reduction in the number of 'advanced' cases in the second screening period was observed. For all stages, the age-specific incidence rates of cases diagnosed outside of the screening programme for the age groups 50-69 years were lower than the corresponding rates in the prescreening period, suggesting a shift from the usual clinical services to the screening programme. Our results confirmed the increase in early-stage cancers occurring at the start of screening, and substantially explained the rise in breast cancer incidence. In addition, our study confirms the importance of cancer registries in monitoring the effect of breast cancer screening and the validity, for this purpose, of the linkage between cancer registries and screening programme databases.",
keywords = "Breast cancer, Cancer registry, Incidence, Mammographic screening, Stage",
author = "E. Buiatti and A. Barchielli and S. Bartolacci and M. Federico and {De Lisi}, V. and L. Bucchi and S. Ferretti and E. Paci and N. Segnan and R. Tumino and D. Balzi and R. Negri and E. Artioli and F. Falcini and E. Crocetti and D. Giorgi and Finarelli, {A. C.} and A. Ponti and G. Ronco and M. Vettorazzi and S. Patriarca and S. Rosso and R. Zanetti",
year = "2003",
month = "8",
doi = "10.1016/S0959-8049(03)00322-8",
language = "English",
volume = "39",
pages = "1776--1782",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "12",

}

TY - JOUR

T1 - The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas

AU - Buiatti, E.

AU - Barchielli, A.

AU - Bartolacci, S.

AU - Federico, M.

AU - De Lisi, V.

AU - Bucchi, L.

AU - Ferretti, S.

AU - Paci, E.

AU - Segnan, N.

AU - Tumino, R.

AU - Balzi, D.

AU - Negri, R.

AU - Artioli, E.

AU - Falcini, F.

AU - Crocetti, E.

AU - Giorgi, D.

AU - Finarelli, A. C.

AU - Ponti, A.

AU - Ronco, G.

AU - Vettorazzi, M.

AU - Patriarca, S.

AU - Rosso, S.

AU - Zanetti, R.

PY - 2003/8

Y1 - 2003/8

N2 - The aim of this study was to examine the effects of mammographic screening programmes on stage-specific incidence of breast cancer. The study compared prescreening and screening periods in seven areas in Italy, primarily evaluating the first screening round. All 17 617 breast cancers (16 554 invasive, 1063 in situ) registered in women aged 40-79 years between 1988 and 1999 were analysed through age-standardised rates and Poisson regression models. For all areas, independent of the baseline rates, the introduction of screening increased incidence for invasive cancers overall and, more markedly, for early cancers (screening/prescreening ratio: range 1.07-1.47 and 1.23-1.82, respectively), modifying the pattern of age-specific rates. The multiple regression analysis showed that the percentage of cases diagnosed at screening explained most of the increase; a residual effect of diagnosis period (screening versus prescreening) suggested a role for 'spontaneous' early detection in ages outside of the screening programme. Advanced cases did not show consistent variations across the registries for those aged 40-79 years (range: 0.91-1.21), whereas a more coherent picture was observed for those aged 50-69 years. In one area, a moderate reduction in the number of 'advanced' cases in the second screening period was observed. For all stages, the age-specific incidence rates of cases diagnosed outside of the screening programme for the age groups 50-69 years were lower than the corresponding rates in the prescreening period, suggesting a shift from the usual clinical services to the screening programme. Our results confirmed the increase in early-stage cancers occurring at the start of screening, and substantially explained the rise in breast cancer incidence. In addition, our study confirms the importance of cancer registries in monitoring the effect of breast cancer screening and the validity, for this purpose, of the linkage between cancer registries and screening programme databases.

AB - The aim of this study was to examine the effects of mammographic screening programmes on stage-specific incidence of breast cancer. The study compared prescreening and screening periods in seven areas in Italy, primarily evaluating the first screening round. All 17 617 breast cancers (16 554 invasive, 1063 in situ) registered in women aged 40-79 years between 1988 and 1999 were analysed through age-standardised rates and Poisson regression models. For all areas, independent of the baseline rates, the introduction of screening increased incidence for invasive cancers overall and, more markedly, for early cancers (screening/prescreening ratio: range 1.07-1.47 and 1.23-1.82, respectively), modifying the pattern of age-specific rates. The multiple regression analysis showed that the percentage of cases diagnosed at screening explained most of the increase; a residual effect of diagnosis period (screening versus prescreening) suggested a role for 'spontaneous' early detection in ages outside of the screening programme. Advanced cases did not show consistent variations across the registries for those aged 40-79 years (range: 0.91-1.21), whereas a more coherent picture was observed for those aged 50-69 years. In one area, a moderate reduction in the number of 'advanced' cases in the second screening period was observed. For all stages, the age-specific incidence rates of cases diagnosed outside of the screening programme for the age groups 50-69 years were lower than the corresponding rates in the prescreening period, suggesting a shift from the usual clinical services to the screening programme. Our results confirmed the increase in early-stage cancers occurring at the start of screening, and substantially explained the rise in breast cancer incidence. In addition, our study confirms the importance of cancer registries in monitoring the effect of breast cancer screening and the validity, for this purpose, of the linkage between cancer registries and screening programme databases.

KW - Breast cancer

KW - Cancer registry

KW - Incidence

KW - Mammographic screening

KW - Stage

UR - http://www.scopus.com/inward/record.url?scp=0041346023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041346023&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(03)00322-8

DO - 10.1016/S0959-8049(03)00322-8

M3 - Article

C2 - 12888374

AN - SCOPUS:0041346023

VL - 39

SP - 1776

EP - 1782

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 12

ER -